Jennifer L Taubert, the EVP of $JNJ, sold 56,471 shares of the company on 09-04-2025 for an estimated $10,040,882. We received data on the trade from a recent SEC filing. This was a sale of approximately 24.1% of their shares of this class of stock. Following this trade, they now own 178,013 shares of this class of $JNJ stock.
$JNJ Insider Trading Activity
$JNJ insiders have traded $JNJ stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOAQUIN DUATO (CEO and Chairman of the Board) sold 125,824 shares for an estimated $22,548,654
- JENNIFER L TAUBERT (EVP, WWC. Innovative Medicine) sold 56,471 shares for an estimated $10,040,882
- JOHN C REED (EVP, Innovative Medicine, R&D) sold 19,137 shares for an estimated $3,129,829
- JOSEPH J WOLK (Exec VP, CFO) sold 16,820 shares for an estimated $2,975,570
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$JNJ Hedge Fund Activity
We have seen 1,743 institutional investors add shares of $JNJ stock to their portfolio, and 2,187 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 7,166,000 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $1,094,606,500
- BLACKROCK, INC. added 4,482,323 shares (+2.2%) to their portfolio in Q2 2025, for an estimated $684,674,838
- INVESCO LTD. removed 4,457,751 shares (-24.1%) from their portfolio in Q2 2025, for an estimated $680,921,465
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,319,402 shares (+20.3%) to their portfolio in Q2 2025, for an estimated $507,038,655
- CAPITAL INTERNATIONAL INVESTORS removed 3,101,458 shares (-83.8%) from their portfolio in Q2 2025, for an estimated $473,747,709
- VANGUARD GROUP INC added 3,085,180 shares (+1.3%) to their portfolio in Q2 2025, for an estimated $471,261,245
- ASSENAGON ASSET MANAGEMENT S.A. added 2,557,388 shares (+159.6%) to their portfolio in Q2 2025, for an estimated $390,641,017
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$JNJ Congressional Stock Trading
Members of Congress have traded $JNJ stock 17 times in the past 6 months. Of those trades, 5 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 07/31.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 06/12.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 06/10.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $100,000 on 05/30, 03/31 and 1 sale worth up to $15,000 on 04/29.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/09, 03/07.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$JNJ Analyst Ratings
Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 08/21/2025
- UBS issued a "Buy" rating on 07/17/2025
- RBC Capital issued a "Outperform" rating on 07/17/2025
- Raymond James issued a "Outperform" rating on 04/16/2025
- Goldman Sachs issued a "Buy" rating on 04/09/2025
To track analyst ratings and price targets for $JNJ, check out Quiver Quantitative's $JNJ forecast page.
$JNJ Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 10 analysts offer price targets for $JNJ in the last 6 months, with a median target of $175.5.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $200.0 on 08/21/2025
- Tim Anderson from B of A Securities set a target price of $175.0 on 07/17/2025
- Matt Miksic from Barclays set a target price of $176.0 on 07/17/2025
- Danielle Antalffy from UBS set a target price of $190.0 on 07/17/2025
- Vamil Divan from Guggenheim set a target price of $167.0 on 07/17/2025
- Shagun Singh from RBC Capital set a target price of $185.0 on 07/17/2025
- Terence Flynn from Morgan Stanley set a target price of $176.0 on 07/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
